Literature DB >> 21184030

Differential forms of p53 in medulloblastoma primary tumors, cell lines and xenografts.

Tzvetomira Philipova1, Ninib Baryawno, Wolfgang Hartmann, Torsten Pietsch, Henrik Druid, John Inge Johnsen, Tomas J Ekström.   

Abstract

Medulloblastoma is the most common malignant brain tumor in childhood. The most prevalent chromosomal abnormalities are isochromosome 17q and loss of 17p, the location of the tumor suppressor gene p53. Mutations in the p53 gene in medulloblastoma are relatively infrequent but have recently been correlated to poor prognosis. Furthermore, the p53 gene encodes nine different isoforms, which may have a profound impact on p53 tumor suppressor activity. Nine medulloblastoma primary biopsy samples, six cell lines from medulloblastoma, and one from a supratentorial PNET, and a medulloblastoma xenograft, along with human brain and visceral tissues, were analyzed by Western blotting, using monoclonal p53 antibodies against two regions in the N-terminus or the central domain. Medulloblastoma primary tissue and xenografts present low molecular weight proteins recognized by both N-terminal p53 antibodies that are absent in all cell lines including the one used for xenografts. Normal visceral organs display short forms of p53, and low levels of canonical p53. Normal brain structures, including cerebellum, contained only canonical size p53 at high levels. In conclusion, our results indicate that the presence of p53 isoforms may play a functional role in medulloblastoma. The observed differences in their presence in cell lines and derived xenografts, suggest that p53 should be investigated in in vivo models rather than in cell lines.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21184030     DOI: 10.3892/ijo.2010.884

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

1.  p53 isoform profiling in glioblastoma and injured brain.

Authors:  R Takahashi; C Giannini; J N Sarkaria; M Schroeder; J Rogers; D Mastroeni; H Scrable
Journal:  Oncogene       Date:  2012-07-23       Impact factor: 9.867

2.  Regulation of Chemosensitivity in Human Medulloblastoma Cells by p53 and the PI3 Kinase Signaling Pathway.

Authors:  Aisha Naeem; Varsha Harish; Sophie Coste; Erika M Parasido; Muhammad Umer Choudhry; Lawrence F Kromer; Chukuemeka Ihemelandu; Emanuel F Petricoin; Mariaelena Pierobon; Muhammad Saad Noon; Venkata Mahidhar Yenugonda; Maria Avantaggiati; Gary M Kupfer; Stanley Fricke; Olga Rodriguez; Chris Albanese
Journal:  Mol Cancer Res       Date:  2021-10-11       Impact factor: 6.333

3.  Expression of p53β and Δ133p53 isoforms in different gastric tissues.

Authors:  Wansheng Ji; Na Zhang; Hongmei Zhang; Jingrong Ma; Hua Zhong; Jianxin Jiao; Zhixing Gao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  Mir-34a mimics are potential therapeutic agents for p53-mutated and chemo-resistant brain tumour cells.

Authors:  Yuen Ngan Fan; Daniel Meley; Barry Pizer; Violaine Sée
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

5.  Role of Δ133p53 isoform in NF-κB inhibitor PDTC-mediated growth inhibition of MKN45 gastric cancer cells.

Authors:  Hong-Mei Zhang; Xiao-Guang Sang; Yan-Ze Wang; Can Cui; Li Zhang; Wan-Sheng Ji
Journal:  World J Gastroenterol       Date:  2017-04-21       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.